119 related articles for article (PubMed ID: 34332107)
1. Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials.
Tawfik GM; Biala M; Yousef YM; Tiwari R; Dobs M; Lotfy CI; Farrag DA; Hue AT; Yotsu RR; Huy NT
Clin Microbiol Infect; 2021 Dec; 27(12):1754-1761. PubMed ID: 34332107
[TBL] [Abstract][Full Text] [Related]
2. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
Schoenmakers A; Mieras L; Budiawan T; van Brakel WH
Res Rep Trop Med; 2020; 11():97-117. PubMed ID: 33117053
[TBL] [Abstract][Full Text] [Related]
3. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study).
Richardus RA; Alam K; Pahan D; Feenstra SG; Geluk A; Richardus JH
BMC Infect Dis; 2013 Oct; 13():456. PubMed ID: 24088534
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.
Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH
Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206
[TBL] [Abstract][Full Text] [Related]
5. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
Richardus JH; Oskam L
Clin Dermatol; 2015; 33(1):19-25. PubMed ID: 25432807
[TBL] [Abstract][Full Text] [Related]
6. Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial.
Dos Santos DS; Duppre NC; Sarno EN; Pinheiro RO; Sales AM; Nery JADC; Moraes MO; Camacho LAB
Trials; 2018 Apr; 19(1):244. PubMed ID: 29685164
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of rifampicin chemoprophylaxis in preventing leprosy in patient contacts: a systematic review of quantitative and qualitative evidence.
Ferreira SMB; Yonekura T; Ignotti E; Oliveira LB; Takahashi J; Soares CB
JBI Database System Rev Implement Rep; 2017 Oct; 15(10):2555-2584. PubMed ID: 29035966
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.
Idema WJ; Majer IM; Pahan D; Oskam L; Polinder S; Richardus JH
PLoS Negl Trop Dis; 2010 Nov; 4(11):e874. PubMed ID: 21072235
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.
Schuring RP; Richardus JH; Pahan D; Oskam L
Vaccine; 2009 Nov; 27(50):7125-8. PubMed ID: 19786134
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysis.
Zodpey SP
Indian J Dermatol Venereol Leprol; 2007; 73(2):86-93. PubMed ID: 17456912
[TBL] [Abstract][Full Text] [Related]
11. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
Shepherd AR; Shepherd E; Brook NR
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
[TBL] [Abstract][Full Text] [Related]
12. Treating BCG-induced disease in children.
Cuello-García CA; Pérez-Gaxiola G; Jiménez Gutiérrez C
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD008300. PubMed ID: 23440826
[TBL] [Abstract][Full Text] [Related]
13. Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis.
Reveiz L; Buendía JA; Téllez D
Rev Panam Salud Publica; 2009 Oct; 26(4):341-9. PubMed ID: 20107683
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.
Richardus RA; Butlin CR; Alam K; Kundu K; Geluk A; Richardus JH
Vaccine; 2015 Mar; 33(13):1562-7. PubMed ID: 25701674
[TBL] [Abstract][Full Text] [Related]
15. Leprosy.
Smith WC; Saunderson P
BMJ Clin Evid; 2010 Jun; 2010():. PubMed ID: 21418690
[TBL] [Abstract][Full Text] [Related]
16. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.
Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A
Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818
[TBL] [Abstract][Full Text] [Related]
17. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
18. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh.
Feenstra SG; Pahan D; Moet FJ; Oskam L; Richardus JH
Lepr Rev; 2012 Sep; 83(3):292-304. PubMed ID: 23356030
[TBL] [Abstract][Full Text] [Related]
19. Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.
Younoussa A; Samidine SN; Bergeman AT; Piubello A; Attoumani N; Grillone SH; Braet SM; Tsoumanis A; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Snijders R; Corstjens P; Ortuno-Gutierrez N; Hoof C; Geluk A; de Jong BC; Hasker E
BMC Infect Dis; 2023 May; 23(1):310. PubMed ID: 37161571
[TBL] [Abstract][Full Text] [Related]
20. The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study.
Fischer EA; de Vlas SJ; Habbema JD; Richardus JH
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1330. PubMed ID: 21949895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
